Eargo

Eargo, Inc. is engaged in the development of hearing aids and headsets solutions. Its products include Eargo Neo HiFi, Eargo Neo, Eargo Max, and Eargo Accessories. The company was founded by Florent Michel, Raphael Michel, and Daniel Shen on November 12, 2010 and is headquartered in San Jose, CA.

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q4 2021

Earnings data Q3 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Eargo reports robust Q4 earnings, eyes growth through innovation

Eargo's Q4 2022 performance showcased strong revenue growth and improved gross margins, supported by successful fundraising efforts. The company's innovative product launches and strategic partnerships position it well for future growth.
While facing challenges in operational areas and economic uncertainties, Eargo's focus on refining strategies, accessing new markets, and driving innovation presents opportunities for sustained growth and market leadership.

Eargo reports robust Q1 earnings, eyes growth amidst industry evolution

Eargo's Q1 performance reflects growth momentum, positive customer reception, and strategic advancements in its business model.
While challenges like cash burn improvement and competition exist, Eargo's strengths in strategy execution and market positioning bode well for future success.
Opportunities in partnerships, market expansion, and innovation position Eargo favorably for continued growth and industry leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Eargo specializes in the design and development of hearing aids. The company also offers online hearing screenings and virtual support, so customers don’t need to have an in-person visit. It offers rechargeable hearing aids that can be controlled with a smartphone. Its innovative product and go-to-market approach address the challenges of traditional hearing aid adoption, including social stigma, accessibility, and cost.

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Eargo, Inc. (NASDAQ: EAR) resulting from allegations that Eargo may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Eargo securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen La

EQUITY ALERT: Rosen Law Firm Encourages Eargo, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation – EAR

New York, New York--(Newsfile Corp. - September 23, 2021) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Eargo, Inc. (NASDAQ: EAR) common stock.Eargo, Inc. designs and markets hearing aids that cost up to $2,500. Eargo went public when it held its Initial Public Offering on October 15, 2020 at $18.00 per share.After the market closed on September 22, 2021, Eargo disclosed "…it is the target of a...

Wolf Popper LLP Announces Investigation on Behalf of Purchasers of Eargo, Inc. (EAR) Common Stock

Eargo Inc (NASDAQ: EAR) stock has plunged to an all-time low since the Company started trading in October 2020. The Company was informed that it is the target of a criminal investigation by the U.S. Department of Justice.

Why Did Eargo Shares Dropped To An All-Time Low?

SAN JOSE, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the 2021 Virtual Wells Fargo Healthcare Conference via web cast. Christian Gormsen, Eargo's President and Chief Executive Officer, is scheduled to present on Thursday, September 9th at 3:20 p.m. Eastern Time (12:20 p.m. Pacific Time).

Eargo to Present at the 2021 Virtual Wells Fargo Healthcare Conference

Eargo Inc (NASDAQ: EAR) reported Q2 revenue of $22.9 million, up 43.7%, surpassing the consensus of $21.97 million driven by an increase in gross systems shipped and a decrease in the sales return accrual rate. Christian Gormsen, President and CEO, said, "the shift in mix towards insurance customers facilitated a lower year-over-year return accrual rate of 24.1% and contributed to non-GAAP gross margin improvement of five percentage points Y/Y.

Eargo Stock Plunges After Mixed Q2 Earnings

Eargo, Inc. (EAR) CEO Christian Gormsen on Q2 2021 Results - Earnings Call Transcript

Increases Full Year Net Revenue Guidance to Between $93 Million and $96 Million Increases Full Year Net Revenue Guidance to Between $93 Million and $96 Million

Eargo Reports Second Quarter 2021 Financial Results

SAN JOSE, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will release financial results for the second quarter 2021 after market close on August 12, 2021. On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.

Eargo to Report Second Quarter 2021 Financial Results on August 12, 2021

New lithium-ion battery delivers highest energy density in Eargo's smallest device to date. New lithium-ion battery delivers highest energy density in Eargo's smallest device to date.

Eargo and VARTA Empower Better Hearing Through all New Eargo 5 Hearing Aid

Start hearing life to the fullest with the ultimate Eargo device, completely redesigned to be customizable to your hearing preferences. Start hearing life to the fullest with the ultimate Eargo device, completely redesigned to be customizable to your hearing preferences.

Eargo Launches Eargo 5 Hearing Aid with Sound Match™ Technology

28-year Coca-Cola Executive and Global Brand Builder Joins Effective June 9, 2021 28-year Coca-Cola Executive and Global Brand Builder Joins Effective June 9, 2021

Eargo Appoints Katie Bayne to Board of Directors

With strong revenue growth and a new product about to launch, hearing aid upstart Eargo could be worth investors' attention.

This Recent Healthcare IPO Posted Solid Earnings, but Wall Street Wasn't Listening

SAN JOSE, Calif., May 19, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced its participation in two upcoming virtual investor conferences. Christian Gormsen, Eargo's President and Chief Executive Officer, is scheduled to present via web cast at the following events:

Eargo to Present at Upcoming Investor Conferences

Eargo started 2021 with reasonable numbers. After solid top-line revenue, the company only hiked the full-year sales guidance by a million and it feels as if it continues to be too conservative.

Eargo: Can You Hear The Appeal?

Eargo, Inc. (EAR) CEO Christian Gormsen on Q1 2021 Results - Earnings Call Transcript

Eargo Reports First Quarter 2021 Financial Results

Eargo ended 2020 on a solid note after it guided cautiously.

Eargo: I Am Slowly Starting To Listen

Boxlight

JetBlue Airways

Livent Corp

Maxar Technologies

As Apple dropped by more than 2%, as did the major indices. The Dow Jones fell 150 points, the S&P 500 dropped 0.8%, and Nasdaq tanked by more than 1.4%.

Today's Top Shorts As Tech Stocks Tank Amid Market Euphoria Concerns

SAN JOSE, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the BofA Securities 2021 Virtual Health Care Conference via web cast. Christian Gormsen, Eargo's President and Chief Executive Officer, is scheduled to present on Thursday, May 13th at 11:45 a.m. Eastern Time (8:45 a.m. Pacific Time).

Eargo to Present at BofA Securities 2021 Virtual Health Care Conference

SAN JOSE, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will release financial results for the first quarter 2021 after market close on May 12, 2021. On the same day, Eargo will host a conference call and webcast at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss its financial results and recent highlights.

Eargo to Report First Quarter 2021 Financial Results on May 12, 2021

Eargo is looking to modernize the hearing aid market, and we're all ears.

Get an Earful of This Growing Healthcare Stock

New Survey Raises Awareness of Hearing Loss Ahead of World Hearing Day on March 3 New Survey Raises Awareness of Hearing Loss Ahead of World Hearing Day on March 3

Eargo Finds the Sounds Americans Miss Most During the Pandemic

Eargo, Inc. (EAR) CEO Christian Gormsen on Q4 2020 Results - Earnings Call Transcript

Provides Full Year 2021 Financial Guidance Provides Full Year 2021 Financial Guidance

Eargo Reports Fourth Quarter and Full Year 2020 Financial Results

SAN JOSE, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will present at the 10th Annual SVB Leerink Global Healthcare Conference via web cast. Christian Gormsen, Eargo's President and Chief Executive Officer, is scheduled to present on Friday, February 26th at 12:00PM Eastern Time.

News for Eargo Stock (EAR)